A critical advance in cancer investigation is arising with the use of nanobodies to restore mutated p53. This crucial malignant inhibitor protein is frequently inactivated in several types of tumors, resulting https://210list.com/story22739177/vhh-fragments-revive-tumor-suppressor-p53-new-potential-pathway-for-cancer-management